藥物成份

共有 21098 個藥物成份

Hydrochloric acid 0.16% Non-ionic surfactant 0.50%

• 關聯藥證數量: 1

Hydrochloric acid 10mmol/L; Acetic acid 9.8mL/L; Ammonium iron(II) sulfate hexahydrate 35.2mg/L

• 關聯藥證數量: 1

Hydrochloric acid(32%):Approx. 2ml/L - component for adjusting the PH

• 關聯藥證數量: 1

Hydrochlorothazide contains not less than 97.5% and not more than 102.0% of C7H8ClN3O4S2, calculated on the dried substance.

• 關聯藥證數量: 1

Hydrochlorothiazide (6-Chloro-3, 4-dihydro-2H-1,2,4-benzothiadiazine-7-sulfonamide 1,1-dioxide).Content：97.5%~102.0% (dried substance.)

• 關聯藥證數量: 1

Hydrochlorothiazide contains not less than 97.5% and not more than 102.0% of C7H8ClN3O4S2 (dried substance).

• 關聯藥證數量: 1

Hydrochlorothiazide contains not less than 98.0 percent and not more than 102.0 percent of C7H8ClN3O4S2, calculated on the dried basis.

• 關聯藥證數量: 1

Hydrochlorothiazide contains not less than 98.0% and not more than 102.0% of C7H8CIN3O4S2, calculated on the dried basis.

• 關聯藥證數量: 1

Hydrochlorothiazide contains not less than 98.0% and not more than 102.0% of C7H8ClN3O4S2, calculated with reference to the dried substance.

• 關聯藥證數量: 1

Hydrochlorothiazide contains not less than 98.0% and not more than the equivalent of 102.0% C7H8ClN3O4S2, calculated with reference to the dried substance.

• 關聯藥證數量: 1

Hydrocloric acid (Colourless to yellowish liquid with perceptible odour).

• 關聯藥證數量: 1

Hydrocortisone Acetate contains 97.0% to 102.0% of C23H32O6 (dried substance).

• 關聯藥證數量: 1

Hydrocortisone Acetate contains NLT 97.0% and NMT 102.0% of C23H32O6, calculated on the dried basis.

• 關聯藥證數量: 1

Hydrocortisone Acetate contains not less than 97% and not more than 102% of C23H32O6 calculated on the dried basis.

• 關聯藥證數量: 1

Hydrocortisone Acetate contains not less than 97.0 % and not more than the equivalent of 103.0 % of C23H32O6, calculated with reference to the dried substance.

• 關聯藥證數量: 1

Hydrocortisone Acetate contains not less than 97.0% and not more than 103.0% of C23H32O6 calculated on the dried basis

• 關聯藥證數量: 1

Hydrocortisone contains NLT 97.0% and NMT 102.0% of C21H30O5, calculated on the dried basis.

• 關聯藥證數量: 1

Hydrocortisone contains not less than 97% and not more than 102% of C21H30O5,calculated on the dried basis

• 關聯藥證數量: 1

Hydrocortisone contains not less than 97.0% and not more than 102.0% of C21H30O5, calculated on the dried basis.

• 關聯藥證數量: 1

Hydrocortisone contains not less than 97.0% and not more than 103.0% of C21H30O5, calculated on the dried basis.

• 關聯藥證數量: 1

Hydrocortisone contains not less than 97.0% and not more than the equivalent of 103.0% of C21H30O5, calculated with reference to the dried substance.

• 關聯藥證數量: 1

Hydrocortisone sodium succinate contains not less than 97.0% and not more than 102.0% of total steroids, calculated as C25H33NaO8, on the dried basis.

• 關聯藥證數量: 1

Hydrogen Peroxide Block\nUltra V Block\nPrimary Antibody Enhancer\nHRP Polymer\nAEC Single Solution \nDAB Plus Substrate\nDAB Plus Chromogen

• 關聯藥證數量: 1

Hydrogen peroxide solution (35%)....918.00g (91.8%) \nAcetic acid.........................80.08g (8%)\nStabilizer P340 (Etidronic Acid).....2.00g (0.2%)

• 關聯藥證數量: 1

Hydromorphone HCL Assay (in the dried substance)：98.0%~102.0%

• 關聯藥證數量: 1

Hydroxide Aluminium Magnesium Co-Dried Gel :\nAluminium oxide 25.0%~35.0%\nMagnesium oxide 25.0%~35.0%

• 關聯藥證數量: 1

Hydroxocobalamin Acetate contains 96.0%~102.0% of C64H93CoN13O17P, calculated on the dried basis.

• 關聯藥證數量: 1

Hydroxocobalamin Acetate contains not less than 96.0% and not more than 102.0% w/w of C62H89CoN13O15P‧C2H4O2 (expressed in acetate)(calculated with reference to the dried substance)

• 關聯藥證數量: 1

Hydroxocobalamin acetate

• 關聯藥證數量: 1

Hydroxychloroquine Sulfate contains not less than 98.0% and not more than 102.0% of C18H26ClN3O‧H2SO4, calculated on the dried basis.

• 關聯藥證數量: 1

Hydroxychloroquine sulfate, 98.0-102.0%(dried substance)

• 關聯藥證數量: 1

Hydroxypropyl Methylcellulose

• 關聯藥證數量: 1

Hydroxypropyl Methylcellulose(HPMC)

• 關聯藥證數量: 1

Hydroxypropyl methylcellulose(HPMC)

• 關聯藥證數量: 1

Hydroxypropyl methylcellulose, HPMC

• 關聯藥證數量: 1

Hydroxyurea contains not less than 97.0% and not more than 103.0% of CH4N2O2

• 關聯藥證數量: 1

Hylan polymers (Hylan A+Hylan B) .....8.0mg\nSodium chloride.....8.5mg\nDisodium hydrogen phosphate.....0.16mg\nSodium dihydrogen phosphate monohrdrate.....0.04mg\nWater for injection q.s.\n以下空白\n

• 關聯藥證數量: 1

Hyoscine Hydrobromide

• 關聯藥證數量: 1

Hyoscine butylbromide content not less than 98.0% and not more than 101.0% of C21H30BrNO4, calculated on the dried basis.

• 關聯藥證數量: 1

Hyoscyamine Sulfate contains NLT 98.5% and NMT 100.5% of hyoscyamine sulfate [(C17H23NO3)2．H2SO4], calculated on the anhydrous basis.

• 關聯藥證數量: 1

Hyoscyamine Sulfate contains not less than 98.5% and not more than 100.5% of (C17H23NO3)2‧H2SO4‧2H2O, calculated on the anhydrous basis.

• 關聯藥證數量: 1

Hyoscyamine sulphate contains not less than 98.5% and not more than 100.5% of (C17H23NO3)2‧H2SO4, calculated on the anhydrous basis.

• 關聯藥證數量: 1

Hyper-immunizing healthy rabbit antisera\nSalmonella standard strains of the organisms\nO-grouping, H and Vi antigens\nSodium azide 0.1 w/v%

• 關聯藥證數量: 1

Hyper-immunizing healthy rabbits antisera

• 關聯藥證數量: 1

Hyper-immunizing healthy rabbits antisera\nSodium azide 0.1 w/v%

• 關聯藥證數量: 1

Hyper-immunizing healthy rabbits with formalin-treated bacterial cells possessing K-antigens or O-group antigens.

• 關聯藥證數量: 1

I-123 MIBG

• 關聯藥證數量: 1

I-125 labeled β2-microglobulin tracer: one 55 mL vial \nCalibrators: five 0.5 mL vials+one 2 mL vial with \"zero\" calibrator.\nControl serum: one vial

• 關聯藥證數量: 1

I-PTH Standards:\nOne vial, 5 mL, labeled A, containing 0 pg/mL I-PTH and six vials, 1 mL each, labeled B-G, containing\napproximate concentrations of 10, 30, 100, 250, 750 and 2000 pg/mL human PTH (1-84) in a protein-based\nbuffer with a non-mercury preservative.\n* DSL-8000 (500 Tubes) contains three sets of standards\nAnti-PTH-Coated Tubes: \nOne hundred (100) plastic tubes with Anti-PTH (39-84) immobilized to the inside wall of each tube. \n* DSL-8000 (500 Tubes) contains five hundred (500) plastic tubes.\n

• 關聯藥證數量: 1

I. Wash Concentrate: containing buffered saline with a nonionic detergent.\nJ. Stopping Solution: containing 0.2 M sulfuric acid.\n

• 關聯藥證數量: 1

IATROSERA IM-I\nIATROSERA IM-II

• 關聯藥證數量: 1

IBUFENAC

• 關聯藥證數量: 1

IBUPROFEN 50 contains not less than 99% and not more than 100.5 % of C13H18O2,calculated on the anhydrous basis.

• 關聯藥證數量: 1

IBUPROFEN 70 contains not less than 99% and not more than 100.5 % of C13H18O2,calculated on the anhydrous basis.

• 關聯藥證數量: 1

ICHTHAMMOL AMMONIUM

• 關聯藥證數量: 1

ICODEXTRIN

• 關聯藥證數量: 1

ICT Calibrator is prepared in a protein-based solution.

• 關聯藥證數量: 1

ID-Anti-D “ for confirmation of Dweak by IAT containing monoclonal anti-D IgG (cell line ESD1).\nPreservatives: trimethoprime and sulfamethoxazole.\n

• 關聯藥證數量: 1

ID-Card “Antigen profile II”, containing human anti-k, human anti-Kpa, human anti-Kpb, monoclonal anti-Jka (cell line MD-15) and monoclonal anti-Jkb, (cell line MS-8), within the gel matrix. The microtube ctl is the nega-tive control.\nPreservative: <0.1% NaN3.\n

• 關聯藥證數量: 1

ID-Card “Antigen profile I”, containing monoclonal anti-P1, antibodies (cell line 650), monoclonal anti-Lea (cell line LM112/161), monoclonal anti-Leb, (cell line LM129/181), human anti-Lua ,human anti-Lub, within the gel matrix. The microtube ctl is the negative control.\nPreservative: <0.1% NaN3.\n\n

• 關聯藥證數量: 1

ID-Card “Rh D+ Phenotype” contains anti-C, anti-c, anti-D, anti-E and anti-e of human origin within the gel matrix, plus ctl microtube for validation of the results. \nPreservative: <0.1% NaN3.\n

• 關聯藥證數量: 1

ID-Card“Antigen profile III” , 2 microtubes with neutral gel and 4 microtubes with polyspecific anti-human globulin (rabbit anti-IgG and monoclonal anti-C3d, cell line C139-9) within the gel matrix (to be used with the specific ID-test sera).\nPreservative: <0.1% NaN3.\n\n

• 關聯藥證數量: 1

ID-Dliuent 1: modified bromelin solution for red cell suspension and reagent for enzyme tests. Preservatives: the antibiotics trimetoprim and sulfamethoxazole.\nID-Dliuent 2: modified LISS for red cell suspension. Preservatives: the antibiotics trimethoprim and sulfamethoxazole.\n\n

• 關聯藥證數量: 1

ID-card Rh-subgroups + Cw + K contains human antibodies, anti-C, anti-Cw, anti-c, anti-E, anti-e und anti-K, within the gel matrix.\nPreservative: <0.1% NaN3.

• 關聯藥證數量: 1

ID-test sera (for “Antigen profile III”): anti-M monoclonal and anti-N monoclonal anti-S, anti-s, anti-Fya and anti-Fyb (human). \nPreservatives: the antibiotics trimetoprime and sulfamethoxazole.\n\n\n

• 關聯藥證數量: 1

ID：32GN Strips：\nL-RHAmnose,N-Acetyl-Glucosamine,D-RIBose,INOsitol,D-SACcharose(sucrose),D-MALtose,ITAconic acid,SUBeric acid,sodium MaloNaTe,sodium ACEtate,LAcTic acid,L-ALAnine,potassium 5-KetoGluconate,GLYconGen,3-hydrOxyBEnzoic acid,L-SERine,D-MANnitol,D-GLUcose,SALicin,D-MELibiose,L-FUCose,D-SORbitol,L-ARAbinose,PROPionic acid,CAPric acid,VALeric acid,trisodium CITrate,L-HIStidine,potassium 2-KetoGluconate,3-hydroOxyBUtyric acid,4-hydrOxyBEnzoic acid,and L-PROline.\nAPI AUX Medium 7 ml：Ammonium sulfate 2.0 g\nMonosodium phosphate 6.24 g\nPotassium chloride 1.5g\nAgar 1.5g\nVitamin solution 10.5 ml\nTrace elements 10.0 ml\nDemineralized water to make 1000ml\npH：7.0-7.2 at 20-25℃

• 關聯藥證數量: 1

IGA Antibody (processed goat sera) 5.0 mL

• 關聯藥證數量: 1

IGA CARTRIDGE x1IGA ANTIBODY(PROCESSED GOAT SERA)7.5MLANTIGEN EXCESS SOLUTION 7.5MLEVAPORATION CAP x2　IGA REAGENT BAR CODE CARDx1

• 關聯藥證數量: 1

IGEPAL CA

• 關聯藥證數量: 1

IGF-I Bead Pack (L2GF12): beads, coated with monoclonal murine anti-IGF-I.IGF-I Reagent Wedge (L2GFA2):Alkaline phosphatase (bovine calf intestine) conjugated to polyclonal rabbit anti-IGF-I, in buffer.IGF-I Adjustors (LGFL, LGFH):Low and High of IGF-I in a protein/buffer matrix.IGF-I Sample Diluent (L2GFZ):concentrated (ready-to-use) IGF-I-free buffer matrix.

• 關聯藥證數量: 1

IGF-I Bead Pack\ncoated with monoclonal murine anti-IGF-I.\nIGF-I Reagent Wedge\n11.5 mL alkaline phosphatase (bovine calf intestine) conjugated to polyclonal rabbit anti-IGF-I, in buffer.\nIGF-I Adjustors\nTwo vials (Low and High), 4 mL each, of IGF-I in a protein/buffer matrix.\nIGF-I Sample Diluent\n20 mL of concentrated IGF-I-free buffer matrix.

• 關聯藥證數量: 1

IGF-I Test Units (LGF1): \nEach unit contains one bead coated with monoclonal murine anti-IGF-I.\n2. IGF-I Reagent Wedge (LGF2): \n7.5 mL alkaline phosphatase (bovine calf intestine) conjugated to polyclonal \nrabbit anti-IGF-I in buffer.\n3. IGF-I Adjustors (LGFL, LGFH): \nTwo vials (Low and High), 4 mL each\n4. IGF-I Pretreatment Solution (LGFA):\n30 mL IGF-I-free buffer matrix.\n5. Control 1 and 2 (LGCOC1, LGCOC2):\nTwo vials containing lyophilized IGF-I and IGFBP-3 in a protein/buffer \nmatrix; 4 mL each.\n

• 關聯藥證數量: 1

IGFBP-3 Bead Pack: coated with murine monoclonal anti-IGFBP-3. IGFBP-3 Reagent Wedge:alkaline phosphatase (bovine calf intestine) conjugated to murine monoclonal anti-IGFBP-3 in buffer. IGFBP-3 Adjustors: Two vials (Low and High), of IGFBP-3 in a protein/buffer matrix. IGFBP-3 Sample Diluent: concentrated IGFBP-3-free protein/buffer matrix.\n

• 關聯藥證數量: 1

IGFBP-3 Standard A/Sample Diluent:\nOne bottle, 55 mL, labeled A, containing 0 ng/mL IGFBP-3 in a protein-based (BSA) buffer with sodium azide as a preservative. \nIGFBP-3 Standards: \nFive vials, labeled B-F, containing concentrations of approximately 2.0, 5.0, 20.0, 50.0, 100.0 ng/mL of\nIGFBP-3 in a protein-based (BSA) buffer. \nAnti-IGFBP-3 [I-125] Reagent: \nOne bottle, 22 mL, containing <10 μCi (370 kBq) of [I-125]-labeled goat Anti-IGFBP-3 polyclonal antibody in\na protein-based (BSA) buffer with sodium azide as a preservative. \n

• 關聯藥證數量: 1

IGG 抗體卡 (血清) 1IGG 抗體卡 (尿液) 1IGG 抗體(處理過的羊血清) 5.0ML疊氮鈉(用作防腐劑) <0.1%(W/W)

• 關聯藥證數量: 1

IGG 試劑筒IGG 抗體 (經過處理的山羊血清) 7.5Ml抗原過剩溶液(AGXS) (經過處理的稀釋人血清) 2.2ML防蒸發蓋 2 IGG 試劑條碼卡 1 疊氮化鈉 (作為防腐劑)<0.1% (重量/重量)

• 關聯藥證數量: 1

IGU Antibody (processed goat sera) 3.9 mLIGU Antigen Excess Solution (processed diluted human serum) 1.2 mL

• 關聯藥證數量: 1

IMAGEN TM ADENOVIRUS REAGENT\nMOUNTING FLUID\nPOSITIVE CONTROL SLIDES

• 關聯藥證數量: 1

IMIDAPRIL HYDROCHLORIDE, when dried, contains not less than 98.5% and not more than 101.0% of [C20H27N3O6？HCl].

• 關聯藥證數量: 1

IMIGLUCERASE

• 關聯藥證數量: 1

IMIPRAMINE

• 關聯藥證數量: 1

IMMULITE HBsAg Confirmatory Kit HBsAg Confirmatory Assay Reagent 1 (LCH1) (Blocking Reagent): One amber glass vial (1.2 mL) of polyclonal goat antibody against HBsAg in a protein-based buffer, with <0.1 g/dL sodium azide.HBsAg Confirmatory Assay Reagent 2 (LCH2) (Control Reagent): One amber glass vial (1.2 mL) of a protein-based buffer, with <0.1 g/dL sodium azide.HBsAg Confirmatory Assay Sample Diluent (LCHZ4): Two bottles (100 mL each) of protein-based buffer, with <0.1 g/dL sodium azide. HBsAg Positive Control (LHBC3): One amber glass vial (8 mL) of human serum with inactivated ad and ay hepatitis B viral antigens, with <0.1 g/dL sodium azide.

• 關聯藥證數量: 1

IMMULITE HBsAgHBsAg Test Units (LHB1)Each barcode-labeled unit contains one bead coated with murine monoclonal anti-HBs.LKHB1: 100 units. LKHB5: 500 units.HBsAg Reagent Wedges (LHBA, LHBB)LHBA: 7.5 mL of a protein-based buffer, with preservative.LHBB: 7.5 mL alkaline phosphatase (bovine calf intestine) conjugated to polyclonal goat anti-HBs in buffer, with preservative. LKHB1: 1 set. LKHB5: 5 setsHBsAg Adjustor (LHBR) 4 mL of human serum with inactivated HBsAg, with preservative LKHB1: 1 vial.LKHB5: 2 vials.

• 關聯藥證數量: 1

IMMULITE OM-MA (CA12-5) Reagent: Each barcode-labeled unit contains one bead coated with murine monoclonal anti-CA125 antibody. 6.5 mL alkaline phosphatase conjugated to rabbit polyclonal anti-CA125 antibody in buffer, Two vials (Low and High), 3 mL each, of CA125 in a nonhuman protein/buffer matrix.\nIMMULITE OM-MA (CA12-5) Sample Diluent: One vial 25 mL of CA125-free nonhuman protein/buffer matrix.

• 關聯藥證數量: 1

IMMULITE Thyroglobulin Reagent: \n？Thyroglobulin Test Units (LTY1): Each barcode-labeled unit contains one anti-ligand-coated bead.\n？Thyroglobulin Reagent Wedge (LTY2): ligand-labeled anti-thyroglobulin murine monoclonal antibody and alkaline phosphatase (bovine calf intestine) \nconjugated to sheep polyclonal anti-thyroglobulin antibody in buffer.\n？ Thyroglobulin Adjustors (LTYL, LTYH): Low and High of lyophilized \nthyroglobulin in a nonhuman serum matrix.\nThyroglobulin Sample Diluent: nonhuman serum matrix.\nThyroglobulin Control Module: lyophilized thyroglobulin in a nonhuman serum matrix.\n\n

• 關聯藥證數量: 1

IMMUNOGLOBULIN ANTILYMPHOCYTE

• 關聯藥證數量: 1

IMMUNOGLOBULIN HORSE

• 關聯藥證數量: 1

IMMUNOGLOBULIN HUMAN SERUM, PLASMATIC ORIGIN

• 關聯藥證數量: 1

IMMUNOGLOBULIN SERUM

• 關聯藥證數量: 1

IMMUNOGLOBULIN SOLUTION STERILE

• 關聯藥證數量: 1

IMMUNOPREP A: Formic Acid 1.2 mL/L、Stabilizer, 70 mL, 215 mL、Sodium Sulfate 31.3 g/L、Stabilizer, 32 mL, 95 mLIMMUNOPREP B: Sodium Carbonate 6.0 g/L、Sodium Chloride 14.5 g/L、Sodium Sulfate 31.3 g/L、Stabilizer, 32 mL, 95 mL IMMUNOPREP C: Paraformaldehyde 10.0 g/L、Buffers, 14 mL, 36 mL

• 關聯藥證數量: 1

IMX Core Reagnet Pack, 100 Tests1.1 bottle(4.3ml) Hepatitis B Core Antigen (Recombinant DNA) Coated Microparticles in buffer with protein stabilizers. Preservative: 0.1% Sodium Azide. 2.1 Bottle(7.8ml) Antibody to Hepatitis B Core Antigen (Human):Alkaline Phosphatase Conjugate in buffer protein stabilizers. Minimum Concentation:0.01 ug/ml preservative:0.1% Sodium Azide, 0.5% Nipaset and 0.0005% Quinolone.3.1 Bottle(10ml) 4 methlumbelliferyl Phosphate in buffer Minimum Concentration:1.2mM. Preservative:0.1% Sodium Azide.4.1 bottle(3.8ml) Specimen Diluent. Dithiothreitol in Acetate Buffer.Concentration:45mM.IMX Core Mode 1 Calibrator1 bottle (8ml) IMX Core Mode 1 Calibrator. Recalicified human plasma, nonreactive for anti-HBc, HBs Ag, anti-HBs, anti-HIV-1. Presevative:0.1% Sodium Azide, Dye: Green (Acid Yellow No.23 and Acid Blue No.9) IMX Probe Cleaning Solution1 Bottle(110ml) IMX Probe Cleaning Solution Containing 2% Tetraethylammoniumhydroxide (TEAH) MEIA 2 Diluent Buffer1000ml, 0.

• 關聯藥證數量: 1

IMX HCV version 3.0 Reagent Pack,100 Tests1. 1 bottle(7.1ml) HCV Antigen (Recombinant, E. coli,yeast)Coated Microparticles2. 1 bottle(7.5ml) Goat Anti-Human IgG:Alkaline PhosphataseConjugate3. 1 bottle(10ml) 4-Methylumbelliferyl Phosphate4. 1 bottle(23ml) Specimen Diluent IMX HCV VERSION 3.0 MODE 1 Calibrator1 bottle (4.9ml) IMX HCV version 3.0 MODE 1 Callbrator,Recalcifiedhuman plasma reactive for anti-HCV, and nonreactive for HBsAg and anti-HIV-1/HIV-2.Two bottles (7ml each) of IMX HCV version Controls are prepared with recalcified human plasma. The Negative Control is nonreactive for anti-HCV,HBsAg and anti-HIV-1/HIV-2.The Positive Control is recalcified human plasma reactive for anti-HCV and nonreactive for HBsAg and anti-HIV-1/2.

• 關聯藥證數量: 1

IMx AFP Reagent Pack, 100 Tests\n1. 1 Bottle (4.5mL) Anti-AFP (Mouse, Monoclonal) Coated Microparticles in buffer with protein stabilizers.\n2. 1 Bottle (6.0mL) Anti- AFP (Mouse, Monoclonal): Alkaline Phosphatase Conjugate in buffer with protein satbilizers (Bovine).\n3. 1 Bottle (10mL) 4-Methylumbelliferyl Phosphate, 1.2mM, in AMP buffer.\n4. 1 Bottle (16mL) Specimen Diluent, buffer calf serum.

• 關聯藥證數量: 1

IMx AFP Specimen Diluent1 Bottle (100mL) IMx AFP Specimen Diluent, buffer calf serum.

• 關聯藥證數量: 1

IMx CA 125 Reagent Pack, 100 Tests 1. 1 Bottle (6mL) Anti-CA 125 (Sheep) Coated Microparticles in TRIS buffer.2. 1 Bottle (8mL) OC 125 Antibody (Mouse, Monoclonal): Alkaline Phosphatase Conjugate in TRIS buffer with protein (bovine and murine) stabilizers. Minimum Concentration: 0.1 mg/mL3. 1 Bottle (10mL) 4-Methylumbelliferyl Phosphate, 1.2mM, in AMP buffer.4. 1 Bottle (12mL) Specimen Diluent, TRIS buffered sheep serum.IMx CA 125 MODE 1 Calibrator3 Bottles (4mL each) of IMx CA 125 MODE 1 Calibrator (C). Assay Value: 50U/ml OC 125 reactive determinants (human) prepared in TRIS buffer with protein (bovine) stabilizers.CA 125 Calibrators 6 Bottles (4 mL each) of CA 125 Calibrators(CA125 Assay value: 0.15、50、125、375、600 U/ml). Calibrators A contains TRIS buffer with protein (bovine) stabilizers.CA 125 Controls3 Bottles (8mL each) of CA 125 Controls with OC 125 reactive determinants (human) prepared in TRIS buffer with protein (bovine) stabilizers (CA 125 Assay value: 30、80、200 U/ml)IMx CA 1

• 關聯藥證數量: 1

IMx CA 15-3 Reagent Pack, 100 Tests 1. 1 Bottle (9mL) 115D8 Antibody (Mouse, Monoclonal) Coated Microparticles in TRIS buffer.2. 1 Bottle (6mL) DF3 Antibody (Mouse, Monoclonal): Alkaline Phosphatase Conjugate in TRIS buffer with protein (bovine) stabilizers. 3. 1 Bottle (10mL) 4-Methylumbelliferyl Phosphate, 1.2mM in AMP buffer 4. 1 Bottle (21mL) Specimen Diluent, TRIS buffer with protein (bovine and murine) stabilizers.CA 15-3 Calibrators (0-250 U/mL)CA 15-3 Controls (35-187.5 U/mL)IMx CA 15-3 Specimen Diluent1 Bottle (100mL) Specimen Diluent, TRIS buffer with protein (bovine and murine) stabilizers

• 關聯藥證數量: 1

IMx CA 19-9 Reagnet Pack, 100 Tests\n1.1 Bottle (4mL) 1116-NS-19-9 (Mouse, Monoclonal) Coated Microparticles in TRIS buffer with protein stabilizers.\n2.1 Bottle (8 mL) 1116-NS-19-9 (Mouse, Monoclonal)：Alkaline Phosphatase Conjugate in TRIS buffer with protein stabilizers.\n3.1 Bottle (10 mL) 4-Methylumbelliferyl Phosphate, 1.2mM, in AMP buffer\n4.1 Bottle (12.5 mL) Specimen Diluent. TRIS Buffer with protein stabilizers.

• 關聯藥證數量: 1

IMx CA 19-9 Specimen Diluent\n1 Bottle (100 mL) IMx CA 19-9 Specimen Diluent

• 關聯藥證數量: 1

IMx CEA Reagent Pack, 100 Tests1. 1 Bottle (5mL) Anti-CEA (Mouse, Monoclonal) Coated Micropaticles 2. 1 Bottle (9mL) Anti-CEA (Mouse, Monoclonal): Alkaline Phosphatase Conjugate 3. 1 Bottle (10mL) 4-Methylumbelliferyl Phosphate4. 1 Bottle (21mL) Wash BufferCEA Calibrators6 Bottles (4mL each) of CEA Calibrators.CEA Controls3 Bottles (8mL each) of CEA Controls.

• 關聯藥證數量: 1